{
    "2021-08-27": [
        [
            {
                "time": "",
                "original_text": "华东医药：被要求说明与华东宁波之间解散事宜相关争议的具体情况",
                "features": {
                    "keywords": [
                        "华东医药",
                        "解散",
                        "争议",
                        "具体情况"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医美太火热：华东医药与子公司内讧了 关联方问题",
                "features": {
                    "keywords": [
                        "医美",
                        "火热",
                        "华东医药",
                        "子公司",
                        "内讧",
                        "关联方问题"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华东医药：案件尚未开庭审理 后续走向存不确定性｜公司问答 诉讼纠纷",
                "features": {
                    "keywords": [
                        "华东医药",
                        "案件",
                        "未开庭",
                        "审理",
                        "不确定性",
                        "诉讼纠纷"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华东医药与子公司“开撕” 或每年损失5000万？｜资讯焦点",
                "features": {
                    "keywords": [
                        "华东医药",
                        "子公司",
                        "开撕",
                        "损失",
                        "5000万"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}